Literature DB >> 19788622

Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.

Fumiyuki Takahashi1, Toshio Kumasaka, Tetsutaro Nagaoka, Midori Wakiya, Hiroaki Fujii, Kazue Shimizu, Koji Uchida, Yoshiteru Morio, Kuniaki Seyama, Okio Hino, Kazuhisa Takahashi, Yoshinosuke Fukuchi.   

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is characterized by fibrocellular intimal proliferation and thrombus formation in small pulmonary arteries and arterioles in patients with metastatic carcinoma. Osteopontin (OPN) is a multifunctional cytokine and adhesive protein, and has been demonstrated to be implicated in fibrosis, neointima formation, arterial occlusion by thrombus, and tumor metastases in cooperation with platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). Herein is described an autopsy case of gastric adenocarcinoma with severe pulmonary hypertension due to PTTM. Histologically, tumor cell emboli markedly induced both fibromuscular intimal thickening and thrombosis, resulting in luminal stenosis and occlusion of small pulmonary arteries and arterioles. Tumor cells, both in the PTTM lesions and primary gastric carcinoma, had positive immunoreactivity for OPN, PDGF, and VEGF. In addition, proliferating fibromuscular intimal cells also showed expression of OPN, PDGF, and VEGF. These findings suggest that OPN may be involved in fibrocellular intimal proliferation and thrombus formation in PTTM together with PDGF and VEGF. To the best of the authors' knowledge this is the first report to demonstrate the possible involvement of OPN in PTTM. It is postulated that OPN is one of the candidate molecules for the development of PTTM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788622     DOI: 10.1111/j.1440-1827.2009.02439.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  14 in total

1.  Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.

Authors:  Fan Lin; Yuyuan Li; Jie Cao; Shaofeng Fan; Jifeng Wen; Guanghui Zhu; Hong Du; Yanxiao Liang
Journal:  Mol Biol Rep       Date:  2010-12-29       Impact factor: 2.316

2.  Pulmonary tumor thrombotic microangiopathy showing aggressive course after transurethral resection of urinary bladder: an autopsy case report.

Authors:  Hiroshi Hirano; Hirotoshi Ichibori; Tomohiko Kizaki; Takuya Matsumoto; Zyunichi Ohka; Takeshige Mori; Masanobu Okamoto; Daisuke Ogasawara; Kohei Kamemura; Ryohei Yoshikawa; Takeshi Itagaki; Yuichi Matsuda; Hiroshi Sano
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

3.  Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer.

Authors:  Hiroyuki Abe; Rumi Hino; Masashi Fukayama
Journal:  Virchows Arch       Date:  2013-03-28       Impact factor: 4.064

4.  Pulmonary tumor thrombotic microangiopathy caused by lung adenocarcinoma: Case report with review of the literature.

Authors:  Machiko Hotta; Mitsuaki Ishida; Fumiyoshi Kojima; Yasuhiro Iwai; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2011-03-18       Impact factor: 2.967

5.  Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases.

Authors:  Yoichiro Okubo; Megumi Wakayama; Kanako Kitahara; Tetsuo Nemoto; Tomoyuki Yokose; Fumihito Abe; Nobuyuki Hiruta; Daisuke Sasai; Minoru Shinozaki; Haruo Nakayama; Takao Ishiwatari; Kazutoshi Shibuya
Journal:  Diagn Pathol       Date:  2011-03-30       Impact factor: 2.644

Review 6.  The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature.

Authors:  Andrew L K Ho; Patryk Szulakowski; Patryk Szulakowsi; Waria H S Mohamid
Journal:  BMC Cancer       Date:  2015-06-03       Impact factor: 4.430

7.  A case report of pulmonary tumor thrombotic microangiopathy (PTTM) caused by esophageal squamous cell carcinoma.

Authors:  Takeshi Fujishiro; Kiyohiko Shuto; Toru Shiratori; Tuguaki Kono; Yasunori Akutsu; Masaya Uesato; Isamu Hoshino; Kentaro Murakami; Shunsuke Imanishi; Toru Tochigi; Yoko Yonemori; Hisahiro Matsubara
Journal:  Esophagus       Date:  2013-07-13       Impact factor: 4.230

8.  A case of locally advanced breast cancer complicated by pulmonary tumor thrombotic microangiopathy.

Authors:  Hak Jin Kim; Mi Hyang Kwak; Sun-Young Kong; Moon-Woo Seong; Han-Sung Kang; Keun Seok Lee; Jungsil Ro
Journal:  Cancer Res Treat       Date:  2012-12-31       Impact factor: 4.679

9.  The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced Pneumonitis.

Authors:  Corey A Carter; Robert Browning; Bryan T Oronsky; Jan J Scicinski; Christina Brzezniak
Journal:  Case Rep Oncol       Date:  2016-01-27

10.  A case of pulmonary tumour thrombotic microangiopathy.

Authors:  Shane McAnearney; Maire Drain
Journal:  Respir Med Case Rep       Date:  2015-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.